Head and Neck Cancer Research Program

Mount Sinai‚Äôs Department of Otolaryngology/Head and Neck Surgery was established as one of the first of its kind in the United States and is ranked among the top ten nationwide by U.S. News & World Report. At the Head and Neck Cancer Research Program, our dynamic team of physician-scientists, biologists, and researchers utilizes a multidisciplinary approach to translational and clinical research. Our goal is to discover new insights into head and neck cancer biology and forge new treatment options, while providing a platform for rapid translation from bench to bedside.  Read more

Research Focus Newsletter

Our newsletter provides up-to-date information about the program's cutting-edge basic, clinical and translational research projects in Head and Neck Cancer.

View Digital Flipbook
View PDF

HPV-related Cancer Vaccine Trial

A clinical trial testing the ADXS 11-001 vaccine for patients who have an HPV-related oral cancer is available at Mount Sinai.

Read more
Contact Us

Julio Aguirre-Ghiso, PhD
Director, Head and Neck Cancer Basic Research
Tel: 212-241-9582
Send e-mail

Brett A. Miles, DDS MD FACS
Assistant Professor
Head and Neck Oral and Maxillofacial Surgery
Oncology Microvascular Reconstructive Surgery
Tel: 212-241-2253

Leslie Waters-Martin
Research Program Coordinator
Tel: 212-241-7107

Advaxis Clinical Trial

Researchers at Mount Sinai are conducting a clinical trial testing a novel vaccine for patients with HPV-related oropharyngeal (tonsil and tongue base) cancer who are eligible to undergo robot-assisted surgery. Watch video